Evidence map›Paper›PMID 38852547›Full record

ArticleEpidemics2024

Agent-based modeling of the COVID-19 pandemic in Florida.

Alexander N Pillai, Kok Ben Toh, Dianela Perdomo, Sanjana Bhargava, Arlin Stoltzfus, Ira M Longini, Carl A B Pearson, Thomas J Hladish

Abstract read
In one paragraph

Article in Epidemics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alexander N PillaiDepartment of Biology, University of Florida, Gainesville, FL, USA.
Kok Ben TohDepartment of Biology, University of Florida, Gainesville, FL, USA; Institute of Global Health and Department of Preventive Medicine, Northwestern University, Chicago, IL, USA.
Dianela PerdomoDepartment of Biology, University of Florida, Gainesville, FL, USA.
Sanjana BhargavaDepartment of Biology, University of Florida, Gainesville, FL, USA.
Arlin StoltzfusOffice of Data and Informatics, National Institute of Standards and Technology, Gaithersburg, MD, USA.
Ira M LonginiDepartment of Biostatistics, University of Florida, Gainesville, FL, USA; Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA.
Carl A B PearsonDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; South African DSI-NRF Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, Republic of South Africa.
Thomas J HladishDepartment of Biology, University of Florida, Gainesville, FL, USA; Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA. Electronic address: tjhladish@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The onset of the COVID-19 pandemic drove a widespread, often uncoordinated effort by research groups to develop mathematical models of SARS-CoV-2 to study its spread and inform control efforts. The urgent demand for insight at the outset of the pandemic meant early models were typically either simple or repurposed from existing research agendas. Our group predominantly uses agent-based models (ABMs) to study fine-scale intervention scenarios. These high-resolution models are large, complex, require extensive empirical data, and are often more detailed than strictly necessary for answering qualitative questions like "Should we lockdown?" During the early stages of an extraordinary infectious disease crisis, particularly before clear empirical evidence is available, simpler models are more appropriate. As more detailed empirical evidence becomes available, however, and policy decisions become more nuanced and complex, fine-scale approaches like ours become more useful. In this manuscript, we discuss how our group navigated this transition as we modeled the pandemic. The role of modelers often included nearly real-time analysis, and the massive undertaking of adapting our tools quickly. We were often playing catch up with a firehose of evidence, while simultaneously struggling to do both academic research and real-time decision support, under conditions conducive to neither. By reflecting on our experiences of responding to the pandemic and what we learned from these challenges, we can better prepare for future demands.

Indexed as

COVID-19SARS-CoV-2FloridaHumansModels, TheoreticalPandemicsSystems AnalysisAgent-based modelingCOVID-19Decision supportPandemic response

Identifiers

PMID38852547
PMCPMC11197045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.